Decreased obestatin in plasma in metabolically obese, normal-weight men with normal glucose tolerance

Diabetes Research and Clinical Practice

Volumn 79, Issue 1, 2008, Pages

  Gao, Xin Yuan ^a   Kuang, Hong Yu ^a   Liu, Xiao Min ^a   Wang, Xue Yan ^b   Pan, Yan Hui ^b   Ma, Xiao Xia ^c  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b First Hospital of Qiqihar City   (China)

^c Third Hospital of Mudanjiang Medical college   (China)

Author keywords

Metabolically obesity; Obestatin

Indexed keywords

CHOLESTEROL; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; OBESTATIN; TRIACYLGLYCEROL;

ADULT; ARTICLE; BODY FAT; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HORMONE BLOOD LEVEL; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; ORAL GLUCOSE TOLERANCE TEST; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; BODY WEIGHT; GLUCOSE TOLERANCE TEST; HUMANS; MALE; OBESITY; PEPTIDE HORMONES;

EID: 37549018125     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2007.07.008     Document Type: Article

References (8)

1. Zhang J.V., Ren P.G., Avsian-Kretchmer O., Luo C.W., Rauch R., Klein C., et al. Obestatin, a peptide encoded by the ghrelin gene, opposes ghrelin's effects on food intake. Science 310 (2005) 996-999
2. Lagaud G.J., Young A., Acena A., Morton M.F., Barrett T.D.., and Shankley N.P. Obestatin reduces food intake and suppresses body weight gain in rodents. Biochem. Biophys. Res. Commun. 357 (2007) 264-269
3. RudermanNB, Schneider S.H., and Berchtold P. The "metabolically obese" normal weight individual. Am. J. Clin. Nutr. 34 (1981) 1617-1621
4. Ruderman N., Chisholm D., Pi-Suneir X., and Schneider S. The metabolically obese normal weight revisited. Diabetes 47 (1998) 699-713
5. Karelis A.D., St-Pierre D.H., Conus F., Rabasa-Lhoret R., and Poehlman E.T. Metabolic and body composition factors in subgroups of obesity: what do we know?. J. Clin. Endocrinol. Metab. 89 (2004) 2569-2575
6. Guo Z.F., Zheng X., Qin Y.W., Hu J.Q., Chen S.P., and Zhang Z. Circulating preprandial ghrelin to obestatin ratio is increased in human obesity. J. Clin. Endocrinol. Metab. 92 (2007) 1875-1880
7. Matthews D.R., Hosker J.P., Rudenski A.S., Naylor B.A., Treacher D.F., and Turner R.C. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 (1985) 412-419
8. Qi X., Li L., Yang G., Liu J., Li K., and Tang Y. Circulating obestatin levels in normal subjects and in patients with impaired glucose regulation and type 2 diabetes mellitus. Clin. Endocrinol. (Oxf) 66 (2007) 593-597